Thus, incretin therapy influences not just metabolism but also sensory and reward pathways. Taste changes tied to satiety, appetite In multivariable analysis, adults who reported increased intensity for sweet taste had higher odds of increased satiety (adjusted OR = 2.02
Furthermore, spontaneous energy intake at the ad libitum lunch was reduced 12% by GLP-1 infusion (Fig
Phase 3 trials have now initiated for overweight and obesity at this point, assessing CagriSema in larger numbers and for longer periods of time. References: Frias JP, et al
Table 2 Clinical evidence of GLP-1R agonists for treating DPN
If you have type 1 diabetes or want to lose weight, talk with your doctor
How GLP-1 Therapies May Lower Blood Pressure The mechanisms behind blood pressure reductions seen with GLP-1 therapy are still being investigated